Edge Biosystems Inc.
San Jose, CA
- UEI
- R6MTUWQQF8L4
- CAGE
- 1PCJ9
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 2032 Concourse Dr, San Jose, CA 95131, USA
- Website
- edgebio.com
- Founded
- 1989
- Employees
- 11-50
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Performa DTR ultra 96-well plate kit | Defense Health Agency | $54,146 | |
| The purchase ensures the continuity of DNA sequencing services, which are vital for the vremt's research and… | Defense Health Agency | $23,439 | |
| Edge plates for case work | Defense Health Agency | $14,620 | |
| Edge plates for case work. | Defense Health Agency | $24,940 | |
| DYE terminator removal (DTR) ultra 96-well plates | Defense Health Agency | $60,200 |
About Edge Biosystems Inc.
Edge Biosystems Inc., a San Jose-based for-profit manufacturer of laboratory supplies and DNA sequencing products, operates as a prime contractor supplying specialized diagnostic reagents and laboratory equipment to the Defense Health Agency and Department of Army Medical Command on a full-and-open, non-set-aside basis. The company holds no subcontracting footprint and competes exclusively as a prime across its federal portfolio.
Edge Biosystems manufactures in-vitro diagnostic substances and DNA analysis consumables, primarily Performa DTR Ultra 96-well plates and related dye terminator removal (DTR) equipment for forensic DNA sequencing and medical examination operations. Concrete representative work includes a $2.9 million single-award BPA established September 1, 2025, through August 31, 2030, with the Defense Health Agency to supply DTR Ultra 96-well plates and laboratory equipment to the Office of the Armed Forces Medical Examiner System; a prior $4.5 million single-award BPA (August 2020 through August 2025) that generated approximately $350,000 in call orders for similar products; and a $24.2 million equipment maintenance agreement with the National Cancer Institute awarded in August 2021. Recent activity includes a $23,438.75 BPA call from the Defense Health Agency on March 6, 2026, for DNA sequencing consumables supporting forensic and diagnostic operations.
Customer concentration heavily favors the Defense Health Agency and Army-affiliated customers. The top two customer agencies account for 72% of awards by count and 99% of combined potential value: the Defense Health Agency (27 awards, $10.2 million combined potential value) and the Department of the Army Medical Command (21 awards, $4.5 million). The remaining portfolio spans the National Institutes of Health, with scattered work under National Cancer Institute, NIAID, and NIDA vehicles totaling less than $300 thousand across twelve awards.
Edge Biosystems executes work primarily through two legacy indefinite-delivery contract vehicles with the Army Medical Command — IDC W81XWH17D0035 (11 task orders, $961 thousand) and IDC W81XWH11D0044 (6 task orders, $611 thousand) — and the prior DHA BPA W81XWH20A9065 (12 task orders, $595 thousand), alongside smaller NIH research vehicles. The company's product mix clusters in NAICS 325413 (In-Vitro Diagnostic Substance Manufacturing, 38 awards) and PSC 6640 (Laboratory Equipment and Supplies, 26 awards), with secondary exposure in biological product manufacturing and testing laboratory services.
Activity has remained modest and relatively flat, ranging from two to five awards per year over the past five years, with 85 total prime awards carrying $15.1 million in combined potential value and $4 million in obligated dollars (26% draw). The recompete window shows minimal churn: only one award with ultimate completion in the next twenty-four months, valued at $23 thousand, indicating stable contract tenure but limited growth pipeline outside the newly awarded 2030-expiring DHA BPA.
Quick answers
What is Edge Biosystems Inc.'s UEI?
Edge Biosystems Inc.'s Unique Entity ID (UEI) in SAM.gov is R6MTUWQQF8L4.
What is Edge Biosystems Inc.'s CAGE code?
Edge Biosystems Inc.'s CAGE code is 1PCJ9.
What is Edge Biosystems Inc.'s primary NAICS code?
Edge Biosystems Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Edge Biosystems Inc. located?
Edge Biosystems Inc.'s physical address in SAM.gov is 2032 Concourse Dr, San Jose, CA 95131, USA.
Is Edge Biosystems Inc. registered in SAM.gov?
Yes. Edge Biosystems Inc.'s SAM.gov registration is active through February 2, 2027.
What is Edge Biosystems Inc.'s most recent federal award?
Edge Biosystems Inc.'s most recent federal contract award is Performa DTR ultra 96-well plate kit (HT942726FE068), from Defense Health Agency, on May 13, 2026.
On GovTribe
See Edge Biosystems Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors